KDM6A and colorectal carcinoma: Collectively, the above findings demonstrated that the downregulation of KDM6A expression was associated with the pathogenesis of rectal cancer, whereas the high KDM6A expression combined with MMR status could be utilized as a potential biomarker for CRC prognosis.